Selected Publications
John A. Glaspy, Nashat Y Gabrail, Patricia A. Locantore-Ford, Gopal C Saha, Elise Hardy, Tyson Lee, Katharina Modelska, David H. Henry: Open‐label, Phase 2 study of roxadustat for the treatment of anemia in patients receiving chemotherapy for non‐myeloid malignancies Journal of Clinical Oncology : 2023.
Henry, DH., Maki RG: Lenalidomide and the expanding toolkit to manage Kaposi sarcoma Clin Canc Res 28 (12): 2485-2487,2022.
Henry DH: Quantitative Nodal Burden and Mortality across Solid Cancers PracticeUpdate : 2022.
Jacobson, D., Cadieux, B., Higano, CS., Henry, DH., Bachmann, BA., Rehn, M., Stopeck, AT., Saad, H: Risk factors associated with skeletal-related events following discontinuation of denosumab treatment among patients with bone metastases from solid tumors: A real-world machine learning approach J Bone Oncol 34 : 100423,2022.
Prasad Siobhan, Barfejani Arnavaz, Henry David, FEVER STATUS AND: ANTIBIOTIC DELIVERY IN THE NEUTROPENIC PATIENT Supportive Care in Cancer MASCC/ISOO Annual Meeting : S1–S207,2022.
Henry D, Barfejani AH, Prasad S: A commentary on: 2021 Top Story in Oncology: Surgically Preventing HPV-Related Anal Cancer in HIV-Infected Individuals PracticeUpdate : 2021.
Makharadze, T, Boccia, R, Krupa, A, Blackman, N, Henry, DH, Gilreath, JA: Efficacy and safety of ferric carboxymaltose infusion in reducing anemia in patients receiving chemotherapy for nonmyeloid malignancies: A randomized, placebo-controlled study (IRON-CLAD) Am J Hematol 96 (12): 1639-1646,2021.
Henry D: A commentary on: Trastuzumab Deruxtecan for HER2-Mutated Metastatic NSCLC PracticeUpdate : 2021.
Henry D: A commentary on: PD-L1b Inhibitors for Nsq-NSCLC PracticeUpdate : 2021.
Henry,D: A commentary on: Cemiplimab With Platinum Doublet Chemo as First-Line for Advanced NSCLC. PracticeUpdate website PracticeUpdate : 2021.
Academic Contact Information
Penn Hematology/Oncology
Abramson Cancer Center
Pennsylvania Hospital, Farm Journal Building
230 West Washington Square
Philadelphia,
PA
19106
Phone: 215-829-6088
Patient appointments: 800-789-7366